OBJECTIVE: To evaluate the efficacy and safety of osmotic-release methylphenidate (OROS-
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …

Objective: Psychostimulants are effective treatments for attention-deficit/hyperactivity
disorder (ADHD) but may be associated with euphoric effects, misuse/diversion, and …

Attention-Deficit/Hyperactivity Disorder (ADHD) frequently co-occurs with substance use
disorder (SUD) and is associated with poor substance-use treatment outcomes. A trial …

This study examined the efficacy and safety of osmotic release oral system methylphenidate
(OROS MPH) as compared with immediate-release MPH (IR MPH) in children with attention …

Background Despite the persistence of attention-deficit/hyperactivity disorder (ADHD) into
adolescence, little is known about the efficacy and tolerability of stimulant medications in this …

Objective: Methylphenidate extended-release orally disintegrating tablets (MPH XR-ODTs)
represent a new technology for MPH delivery. ODTs disintegrate in the mouth without water …

Objective: The purpose of this study was to assess the time of onset and time course of
efficacy over 12.0 hours of extended-release multilayer bead formulation of methylphenidate …

Background Psychostimulants are considered first-line pharmacotherapy for youth with
attention-deficit/hyperactivity disorder (ADHD), but questions remain regarding the …

Objective: The aim of this study was to compare efficacy and safety of two long-acting
formulations of methylphenidate (MPH) for attention-deficit/hyperactivity disorder (ADHD) in …

Objective: To assess the effect of Osmotic-Release Oral System (OROS) methylphenidate
(MPH) on a variety of measures evaluating academic performance, cognition, and social …